Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ChromaDex investigates "next generation resveratrol"

This article was originally published in The Tan Sheet

Executive Summary

The phytochemical developer teams with investigators at the University of Mississippi Medical Center in Jackson to study the impact of pTeroPure pterostilbene on cardiovascular health, glucose levels, anti-aging, cognitive function and metabolic disorders. Irvine, Calif.-based ChromaDex touts the ingredient in a Sept. 7 release as chemically related to resveratrol, but with "significantly higher activity." Researchers will measure the ingredient's impact on participants' cholesterol, blood pressure and inflammatory markers in urine

You may also be interested in...



SupplySide West In Brief

Stevia pioneer to re-launch Symfre

Dr Reddy’s Posts Surprise Q3 Loss With NuvaRing Write-Off

Dr Reddy’s Laboratories reported an unexpected third-quarter consolidated net loss after taking a $156m charge related to its generic version of the NuvaRing contraceptive. However, the company’s shares jumped on a robust underlying performance that was praised by analysts.

Philips Delivers On Aim To Focus Exclusively On Health And Healthtech

Royal Philips is planning to sell its domestic appliance business to better focus on its strategic aims in health technology. The group made the announcement as it unveiled 2019 sales up 4.5% on a comparable basis.

Topics

UsernamePublicRestriction

Register

PS104488

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel